medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2011, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2011; 9 (3)

UVA-1 for pediatric linear scleroderma. First mexican report

Poletti VED, Chávez FMA, Méndez BSI, Muñoz SR, Morales MA

Language: Spanish
References: 31
Page: 196-200
PDF size: 142.59 Kb.


ABSTRACT

9-year-old female patient with lineal scleroderma localized at right superior extremity and with decrease of range of motion. The patient presented unfavorable response to treatment with mometasone 0.1%, futicasone 0.05%, coal tar, urea, and salicylic acid. She was managed with segmental UVA-1 phototherapy, 340 nm, low mode, with ultrasonographic surveillance. On a 3-month period she had complete sclerosis involution, and recuperated joint motion.


REFERENCES

  1. Laguna-Argente C, García-Melgares ML, Febrer-Bosch I. “Morfea infantil”. Piel 2009; 24(1): 28-34.

  2. Fernández-Bussy R, Gatti CF, Porta-Guardia C. Fundamentos en Dermatología Clínica. 1a ed. Buenos Aires, Ediciones Journal, 2011: 229-39.

  3. Peterson LS, Nelson AM, Su WP. “Classification of morphea (localized scleroder ma)”. Mayo Clin Proc 1995; 70: 1068-76.

  4. Vierra E, Cunningham B. “Morphea and localized scleroderma in children”. Sem Cutan Med Surg 1999; 18: 210-25.

  5. Hunzelmann N, Krieg T. “Scleroderma: from pathophysiology to novel therapeutic approaches”. Exp Dermatol 2010; 19: 393-400.

  6. Dutz J. “Treatment options for localized scleroderma”. Skin Therapy Lett 2000; 5: 3-5.

  7. Zulian F, Athreya B. “Treatment of localized scleroderma in childhood”. Br J Dermatol 2007; 156: 1364.

  8. Poletti ED, Moreno GJ, Castillo VF, Amaya M, et al. “Propuesta de guías mexicanas de fototerapia y fotoquimioterapia”. Dermatología Rev Mex 2002; 46(5): 217-223.

  9. Kerscher M, Volkenandt M, Gruss C, Reuther T, Kobyletzki G, Freitag M, et al. “Low dose UVA phototherapy for localized scleroderma”. J Am Acad Dermatol 1998; 38: 21-34.

  10. Dawe RS. “Ultraviolet A1 phototherapy”. Br J Dermatol 2003; 148: 626- 637.

  11. Kollmar AA, Mempel M, Hein R, Ring J, Eberlein B. “Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study”. Br J Dermatol 2010; 162: 445-447.

  12. Kerschner M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M, et al. “Low-dose UVA1 phototherapy for treatment of localized scleroderma”. J Am Acad Dermatol 1998; 38: 21-26.

  13. Scharffetter K, Wlaschek M, Hogg A, Schothost A, Goerz G, Krieg T, et al. “UVA irradiation induced collagenase in human dermal fibroblasts in vitro and in vivo”. Arch Dermatol 1991; 283: 506-511.

  14. Tuchinda C, Kerr HA, Taylor CR, Jacobe H, et al. “UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States”. Photodermatol Photoimmunol Photomed 2006; 22: 247-253.

  15. Gruss CJ, Von Kobyletzki G, Behrens-Williams SC, Lininger J, et al. “Effects of low dose ultraviolet A-1 on morphea”. Photodermatol Photoimmunol Photomed 2001; 17: 149-55.

  16. Rosenkranz M, Agle L, Efthimiou P, Lehman T. “Systemic and localized scleroderma in children. Current and future treatment options”. Pediatr Drugs 2006; 8: 85-97.

  17. Kreuter A, Krieg T, Worm M, Wenzel J, Gambichler T, Kuhn, et al. “Diagnosis and Therapy of Localized Scleroderma”. JDDG 2009; 7: S1- S12: 1610-1614.

  18. Zulian F, Vallongo C, Woo P, et al. “Localized scleroderma in childhood is not just a skin disease”. Arthritis Rheum 2005; 52: 2873-8122.

  19. Mayorquin FJ, McCurley TL, Levernier JE, Myers LK, Becker JA, Graham TP, et al. “Progression of childhood linear scleroderma to fatal systemic sclerosis”. J Rheumatol 1994; 21: 1955-1957.

  20. Dytoc M, Ting PT, Man J, Sawyer P, Rionitto L. “First case series on the use of imiquimod for morphoea”. Br J Dermatol 2005; 153: 815-820.

  21. Myers SL, Cohen JS, Sheets PW. “B-mode ultrasound evaluation of skin thickness in progressive systemic sclerosis”. J Rheumatol 1986; 13: 577-580.

  22. Li SC, Liebling MS, Haines KA, Weiss JE, Prann A. “Initial evaluation of an ultrasound measure for evaluating the activity of skin lesions in pediatric localized scleroderma”. Arthritis Care Res (Hoboken) 2010; Nov 30.

  23. Black CM. “Prognosis and management of scleroderma and sclerodermalike disorders in children”. Clin Exp Rheumatol 1994; 12(Suppl 10): S75-S81.

  24. Zulian F, Athreya B. “Treatment of localized scleroderma in childhood”. Br J Dermatol 2007; 156: 1364.

  25. Cunningham BB, Landello ID, Langman C, Sailer DE, Paller AS. “Topical calcipotriol for morphea/linear scleroderma”. J Am Dermatol 1998; 39: 211-215.

  26. Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Rocken M. “Treatment of localised scleroderma with PUVA bath photochemotherapy” [letter]. Lancet 1994; 343: 1233.

  27. Kerscher M, Dirschka T, Volkenandt M. “Treatment of localized scleroderma by UVA1 phototherapy”. Lancet 1995; 346: 1166.

  28. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M. “Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts”. Lancet 1997; 350: 1295-1296.

  29. Andres C, Kollmar A, Mempel M, Hein R. “Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study”. Br J Dermatol 2010 Feb 1; 162(2): 445- 447.

  30. Jacobe HT, Cayce R, Nguyen J. “UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V”. Br J Dermatol 2008; 159(3): 691-696.

  31. Kreuter A, Hyun J, Stucker M, Sommer A, Altmeyer P, Gambichler T. “A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma”. J Am Acad Dermatol 2006; 54: 440-447.




2020     |     www.medigraphic.com